ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Reports On AACR Scientific Sessions

May 21, 1976

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975

Computer Learning May Help Women In Treatment Decision

October 30, 2009

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013